Abstract
Scleroderma heart disease is a major risk of death in systemic sclerosis (SSc). Mechanisms underlying myocardial damage are still unclear. We performed an extensive study of SSc patients with recent-onset symptoms for heart disease and examined the efficacy of immunosuppressive therapy.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 526-535 |
| Numero di pagine | 10 |
| Rivista | Seminars in Arthritis and Rheumatism |
| Volume | 43 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2013 |
Keywords
- ANCA
- Heart disease
- Myocarditis
- Parvovirus B19
- Systemic sclerosis
- Treatment
Fingerprint
Entra nei temi di ricerca di 'Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver